For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...

Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...

“It was, yes, that makes sense. Let’s give that a try.” By then, he was focused on chronic myelogenous leukemia—a type of ...

In addition to developing WU-CART-007, a drug candidate in clinical trials for treating relapsed or refractory T-cell acute ...

Two-thirds of the money is slated to be used for the Cullman County District Attorney’s Office, with the remaining third ...

My son sighed. Then he warned me about the ravages of acute myelogenous leukemia, the disease that had claimed Coach Landry's life. Landry's death prompted an outpouring of emotion from fans in ...

The World Health Organization has defined chronic disease as non-communicable diseases enduring for long durations (five-year ...

Nowell and Hungerford started their search by investigating cells from individuals with acute myelogenous leukemia (AML). They found no consistent chromosomal abnormalities in these patients.

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

"Treatment options for myelofibrosis-related anemia have been limited. We are proud to offer this treatment alternative for Canadian patients to address this critical unmet need and other ...

Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...